6Heil G, Herrman F, Hoelzer D, et al. GM-CSF priming in the therapy of de novo acute myeloid leukemia patlients: an update of a double blind randomized placebo controlled trial. Ann Hematol, 1997, 74 (Suppl 1):176-179.
7Steen R, Tjonnford, G E, Egeland T, et al. Comparison of the phenotype and clonogenicity of normal CD34+ cells from umbilical cord blood, granulocyte colony-stimulating factor mobilized peripheral blood, and adult human bone marrow. Hematotherapy, 1994, 4
8Shen S H, Liang D C, Lin H C. High dose cytarabine chemotherapy with or without G-CSF for child acute leukemia. Am J Hematol, 1998, 58:20-23.
9Stone R M, Mager R J. Treatment of the newly diagnosed adult with de novo acute myeloid leukemia. Hematol Oncol Clin North Am, 1993,7:47-64.
10Mayani H, Lansdorp P M. Biology of human umbilical cord blood- derived hematopoietic stem/progenitor cells. Stem Cells, 1998,16:153-165.
5Gluckman E, Broxmeyer HE, Auerbach AD, et al. Hematopoletic reconstitution in a patient with Fanconi' s anemia by means of umbilical cord blood from an HLA-identical sibling. E Engl J Med, 1989;321:1174-1178.
6Behrman RE, Kliegman RM, Jenson HB. Nelson Textbook of Pediatrics. 16^th ed. Beijing: Science Press, Harcourt Asia, WB Saunders, 2001 ;493-495.
7Ling FW, Duff P. Obstetrics & Gynecology, Principles and Practice. 1^st ed. Beijing: People Health Press, McGraw-Hill, 2001 ;534-544.
8Thorp JA, Rushing RS. Antepartum and intrapartum fetal assessment umbilical cord blood gas analysis. Obstet Gynecol Clin North Am, 1999 ;26 (4) :695-709.
9Rocha V, Arcese W, Sanz G, et al. Prognostic factors of outcome after unrelated cord blood transplant (UCBT) in adults with hematologic malignancies. Blood, 2000;96:587.
10Barker JN, Weisdorf DJ, DeFor TE, et al. Multiple unit unrelated donor umbilical cord blood transplantation in high risk adults with hematologic malignancies: impact on engraftment and chlmerism. Blood, 2002 ; 100 ( suppl 1 ) : 41.
